Vista Klinik
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept (NCT04287348) | Vista Klinik | 2020-07-20 |
Track Vista Klinik automatically
Every clearance here is in the API, with alerts when new ones post.